Bristol-Myers Squibb Company (BMY) is among the 10 Best Passive Income Stocks to Buy Now. The company declared a quarterly dividend of $0.62 per share on June 17, maintaining its consistent track record. Bristol-Myers has increased payouts for 16 years and boasts 93 years of uninterrupted payouts, offering a 5.2% dividend yield as of July 10.

In the first quarter of 2025, Bristol-Myers Squibb Company (BMY) maintained a strong cash position with $10.8 billion in cash and cash equivalents. Despite a 5.6% YoY revenue decline to $11.2 billion, the company exceeded analyst estimates by $494.6 million. The stock has surged by 16% in the past year.

Bristol-Myers Squibb Company (BMY) is a leading American multinational pharmaceutical company known for its innovative medicines. While it presents investment potential, some believe other AI stocks offer better upside with less risk. For a promising undervalued AI stock benefiting from current economic trends, check out the best short-term AI stock in a free report.

No disclosures provided in the article.

Read more at Yahoo Finance: Can Bristol-Myers Squibb Company (BMY) Provide Stable Long-Term Income?